{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-009112","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2025-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.837563+00:00","generated_at":"2026-05-18T09:15:35.670459+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ProMIS Neurosciences gets additional 180-day Nasdaq compliance period for bid price deficiency until Dec 29, 2025","bullets":["Nasdaq granted a second 180-day compliance period until December 29, 2025, to regain $1.00 minimum bid price.","Company may consider a reverse stock split or other actions to cure the deficiency.","If compliance not achieved by Dec 29, 2025, Nasdaq may delist Common Shares; no assurance of success.","Common shares continue trading on Nasdaq Capital Market under ticker PMN during this period."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-009112","json":"https://secwatch.observer/filing/0001558370-25-009112.json","markdown":"https://secwatch.observer/filing/0001558370-25-009112.md","text":"https://secwatch.observer/filing/0001558370-25-009112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000155837025009112/0001558370-25-009112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000155837025009112/pmn-20250703x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:15:35.670459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}